CRT 2025: Artificial Intelligence in Coronary Artery Disease – Diagnosis and Intervention

Laura Simson, MA

June 2025

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Cath Lab Digest or HMP Global, their employees, and affiliates.

The integration of artificial intelligence (AI) into the diagnosis and management of coronary artery disease (CAD) is no longer just an aspiration: it is already happening. Current technology offers clinicians new tools for early detection, risk stratification, procedural planning, and post-intervention prognostication. In the AI session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.

Click here to finish reading on the Journal of Invasive Cardiology page, with more of Dr. Ran Kornowski's artificial intelligence presentation at CRT 2025, focusing on:

• Pre-Intervention Screening and Diagnosis

• Procedural Integration

• Post-Procedure and Prevention

• Challenges to Implementation

Continue reading:

Artificial Intelligence in Coronary Artery Disease Diagnosis and Intervention

Find More:

CLD Home

Cardiovascular Ambulatory Surgery Centers (ASCs) Topic Center

News

Case Reports

Grand Rounds With Morton Kern, MD

Peripheral Artery Disease Topic Center

Watch: Cath Lab Live Videos

Podcasts: Cath Lab Conversations

Go to Cath Lab Digest's Current Issue

Go to the Journal of Invasive Cardiology Issue

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

thrombectomy

Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology

01/27/2026

Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.

Penumbra recently launched the...

01/27/2026

Cath Lab Digest

AI Cardiac Imaging Software

Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access

01/27/2026

New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...

New York, NY – In the lead-up to...

01/27/2026

Cath Lab Digest

Patent Foramen Ovale Detection

BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection

01/27/2026

The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...

The FOQUS ultrasound system,...

01/27/2026

Cath Lab Digest

AI Plaque analysis

Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis

01/21/2026

DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...

DENVER,...

01/21/2026

Cath Lab Digest

AI Plaque analysis

Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque

01/21/2026

CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...

CALGARY, Alberta -- Circle...

01/21/2026

Cath Lab Digest

Acquisitions

Haemonetics Acquires Vivasure Medical Limited

01/21/2026

Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...

Vivasure's PerQseal® Elite...

01/21/2026

Cath Lab Digest

Early CAD Detection

Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key

01/21/2026

In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...

In the “Mammography and Breast...

01/21/2026

Cath Lab Digest

Radiation Protection Systems

Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study

01/21/2026

Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.

Final results of NOVARAD...

01/21/2026

Cath Lab Digest

Technology & Health Literacy

ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards

01/21/2026

ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.

ECRI experts say that chatbots...

01/21/2026

Cath Lab Digest

CAD Risk Factors

North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women

01/19/2026

The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.

The paper, “Police-Related...

01/19/2026

Cath Lab Digest

CRT 2025: Artificial Intelligence in Coronary Artery Disease – Diagnosis and Intervention

Subscriber

Clinical & Industry News

HMP Global Products

Events